Death panel

The FDA is poised, for the first time, to withdraw its approval for a drug because it is too expensive.

This entry was posted on Friday, December 17th, 2010 at 5:15 pm and is filed under Political. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a comment